Orphapacket:
  AverageAgeOfOnsets:
  - AverageAgeOfOnset:
      value: Adolescent
  - AverageAgeOfOnset:
      value: Adult
  - AverageAgeOfOnset:
      value: Elderly
  DisorderType:
    PURL: http://www.orpha.net/ORDO/Orphanet_377788
    value: Disease
  ExternalReferences:
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '109720'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '613007'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '613008'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '614220'
      Source: OMIM
  - ExternalReference:
      DisorderMappingRelation: BTNT (ORPHA code's Broader Term maps to a Narrower
        Term)
      Reference: '614221'
      Source: OMIM
  Genes:
  - Gene:
      ExternalReferences: []
      Name: interleukin 12 receptor subunit beta 1
      Symbol: IL12RB1
  - Gene:
      ExternalReferences: []
      Name: Spi-B transcription factor
      Symbol: SPIB
  - Gene:
      ExternalReferences: []
      Name: interleukin 12A
      Symbol: IL12A
  - Gene:
      ExternalReferences: []
      Name: interferon regulatory factor 5
      Symbol: IRF5
  - Gene:
      ExternalReferences: []
      Name: transportin 3
      Symbol: TNPO3
  - Gene:
      ExternalReferences: []
      Name: membrane metalloendopeptidase like 1
      Symbol: MMEL1
  - Gene:
      ExternalReferences: []
      Name: POU class 2 homeobox associating factor 1
      Symbol: POU2AF1
  - Gene:
      ExternalReferences: []
      Name: TNF superfamily member 15
      Symbol: TNFSF15
  Label: Primary biliary cholangitis
  ORPHAcode: '186'
  ORPHApacketId: '186'
  PURL: http://www.orpha.net/ORDO/Orphanet_186
  Parents:
  - Parent:
    - Label: Rare biliary tract disease
      ORPHAcode: '101941'
  - Parent:
    - Label: Disease associated with a genetic susceptibility or tested for a biomarker
      ORPHAcode: '231957'
  - Parent:
    - Label: Rare disorder potentially indicated for liver transplant
      ORPHAcode: '506210'
  Phenotypes:
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000952
      HPOTerm: Jaundice
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000989
      HPOTerm: Pruritus
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001278
      HPOTerm: Orthostatic hypotension
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001395
      HPOTerm: Hepatic fibrosis
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001399
      HPOTerm: Hepatic failure
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001402
      HPOTerm: Hepatocellular carcinoma
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0001409
      HPOTerm: Portal hypertension
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002841
      HPOTerm: Recurrent fungal infections
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0002960
      HPOTerm: Autoimmunity
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0003119
      HPOTerm: Abnormal circulating lipid concentration
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0003155
      HPOTerm: Elevated alkaline phosphatase
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0003493
      HPOTerm: Antinuclear antibody positivity
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0003496
      HPOTerm: Increased circulating IgM level
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0011040
      HPOTerm: Abnormality of the intrahepatic bile duct
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0012203
      HPOTerm: Onychomycosis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0000939
      HPOTerm: Osteoporosis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001262
      HPOTerm: Excessive daytime somnolence
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0001541
      HPOTerm: Ascites
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002360
      HPOTerm: Sleep disturbance
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0002608
      HPOTerm: Celiac disease
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0003073
      HPOTerm: Hypoalbuminemia
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0003261
      HPOTerm: Increased circulating IgA level
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0003270
      HPOTerm: Abdominal distention
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0012115
      HPOTerm: Hepatitis
  - Phenotype:
      HPOFrequency: Occasional (29-5%)
      HPOId: HP:0012378
      HPOTerm: Fatigue
  - Phenotype:
      HPOFrequency: Very rare (<4-1%)
      HPOId: HP:0004386
      HPOTerm: Gastrointestinal inflammation
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0000953
      HPOTerm: Hyperpigmentation of the skin
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0001394
      HPOTerm: Cirrhosis
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002613
      HPOTerm: Biliary cirrhosis
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0002908
      HPOTerm: Conjugated hyperbilirubinemia
  - Phenotype:
      HPOFrequency: Very frequent (99-80%)
      HPOId: HP:0011971
      HPOTerm: Dermatographic urticaria
  - Phenotype:
      HPOFrequency: Frequent (79-30%)
      HPOId: HP:0000820
      HPOTerm: Abnormality of the thyroid gland
  Prevalences:
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: '[EXPERT]_ORPHANET'
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: '[EXPERT]_22245904[PMID]'
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Worldwide
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 22245904[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Europe
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 17873609[PMID]_22562114[PMID]_24387641[PMID]_17918011[PMID]_22961000[PMID]_10421645[PMID]_9279616[PMID]_20347176[PMID]_24502439[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 1 000 000
      PrevalenceGeographic: France
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 20347176[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 17873609[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Spain
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 17873609[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Iceland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 22562114[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Iceland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 22562114[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Netherlands
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 24387641[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Netherlands
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 24387641[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Denmark
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 17918011[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Denmark
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 17918011[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 17918011[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Finland
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 17918011[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 22961000[PMID]_9279616[PMID]_10421645[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 11113084[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: United States
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 11113084[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Canada
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 19821525[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Canada
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 19821525[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Australia
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 15300579[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Israel
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 16308995[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: China
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 20815889[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Brunei Darussalam
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 21134832[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Brunei Darussalam
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 21134832[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-5 / 10 000
      PrevalenceGeographic: Greece
      PrevalenceQualification: Value and class
      PrevalenceType: Point prevalence
      Source: 24502439[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: Greece
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 24502439[PMID]
      ValMoy: no data
  - Prevalence:
      PrevalenceClass: 1-9 / 100 000
      PrevalenceGeographic: United Kingdom
      PrevalenceQualification: Value and class
      PrevalenceType: Annual incidence
      Source: 10421645[PMID]_9279616[PMID]
      ValMoy: no data
  Synonyms:
  - Synonym: Hanot syndrome
  - Synonym: PBC
  - Synonym: Primary biliary cirrhosis
  TextSection:
    Contents: A rare autoimmune cholestatic liver disease characterized by autoimmune
      mediated damage of small intrahepatic bile ducts leading to cholestasis fibrosis
      and potential cirrhosis.
    TextSectionType: Definition
  TypeOfInheritances:
  - TypeOfInheritance:
      value: Multigenic/multifactorial
  - TypeOfInheritance:
      value: Unknown
  copyright: Orphanet (c) 2022
  creationDate: '2022-11-28 11:04:13'
  version: 1.3.18 / 4.1.7 [2022-07-12] (orientdb version)
